TABLE 3.
Overall |
Subjects Under Age 18 |
Subjects Age 18 and Older |
|||||||
---|---|---|---|---|---|---|---|---|---|
Characteristic | Mean | SD | Range | Mean | SD | Range | Mean | SD | Range |
fMRI studies (N=38) | |||||||||
Ageb (years) | 29.2 | 7.5 | 8–65 | 13.5 | 1.6 | 8–17 | 34.4 | 9.5 | 17–65 |
Percent femalec | 58.3 | 21.3 | 16–100 | 77.7 | 17.2 | 50–100 | 51.8 | 19.9 | 16–79 |
Percent medicated | 16.4 | 30.4 | 0–100 | 0.8 | 1.5 | 0–4.5 | 21.7 | 33.5 | 0–100 |
EEG studies (N=12) | |||||||||
Aged (years) | 19.9 | 7.2 | 8–65 | 13.9 | 2.5 | 8–17 | 26.0 | 4.4 | 18–65 |
Percent female | 70.2 | 32.2 | 48–100 | 87.0 | 26.0 | 48–100 | 70.8 | 17.4 | 55–100 |
Percent medicated | 18.7 | 16.7 | 0–41 | 15.8 | 15.9 | 4.5–27 | 20.6 | 20.5 | 0–41 |
Some studies did not report these characteristics.
Significant difference between groups in mean age, p<0.001.
Significant difference between groups in percent female, p<0.01.
Significant difference between groups in mean age, p<0.01.